Advertisement

International Journal of Clinical Pharmacy

, Volume 38, Issue 2, pp 191–194 | Cite as

Medical care and drug-related problems: Do doctors and pharmacists speak the same language?

  • J. W. Foppe van MilEmail author
  • Tommy Westerlund
  • Lawrence Brown
  • Timothy F. Chen
  • Martin Henman
  • Kurt Hersberger
  • James McElnay
  • Martin Schulz
Commentary

Abstract

Optimal communication between physicians and pharmacists is important for patient care. However, pharmacists and doctors do not always seem to understand each other. They have been professionalized differently, and do not always speak the same language. Especially in the areas of prescribing, medication review, and medicine use, there can be differences in views. This contribution clarifies some essential concepts that doctors and pharmacists use. Thus we hope that our commentary contributes to a better understanding of each other's role and the importance of interprofessional cooperation for the benefit of the patient.

Keywords

Concepts Drug-related problems Medication errors Medicine Pharmacy Terminology 

Notes

Funding

This commentary was created without special funding.

Conflicts of interest

The authors have no conflicts of interest, but the opinions or assertions in this article are the personal professional views of the authors and are not to be construed as official or as necessarily reflecting the views of the employers, or organisations to which they are affiliated.

References

  1. 1.
    Institute of Medicines. To err is human: building a safer health system. In: Kohn LT, Corrigan JM, Donaldson MS, editors. Washington; 1999. ISBN: 0-309-06837-1.Google Scholar
  2. 2.
    Phillips DP, Christenfeld N, Glynn LM. Increase in US medication-error deaths between 1983 and 1993. Lancet. 1998;351(9103):643–4.CrossRefPubMedGoogle Scholar
  3. 3.
    Stelfox HT, Palmisani S, Scurlock C, Orav EJ, Bates DW. The “To err is human” report and the patient safety literature. Qual Saf Health Care. 2006;15:174–8.CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Larizgoitia I, Bouesseau MC, Kelley E. WHO efforts to promote reporting of adverse events and global learning. J Public Health Res. 2013;2(3):e29. doi: 10.4081/jphr.2013.e29 (eCollection 2013 Dec 1).CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Oxford University Press. Oxford Dictionairy (UK English). http://www.oxforddictionaries.com/. Last accessed 7-4-2015.
  6. 6.
    Benjamin J, Basger BJ, Moles RJ, Chen TF. Development of an aggregated system for classifying causes of drug-related problems. Ann Pharmacother. 2015;49:405–18.CrossRefGoogle Scholar
  7. 7.
    Meyboom RB, Lindquist M, Egberts AG. An ABC of drug-related problems. Drug Saf. 2000;22:415–23.CrossRefPubMedGoogle Scholar
  8. 8.
    van Mil JWF, Westerlund LOT, Hersberger KE, Schaefer MA. Drug-related problem classification systems. Ann Pharmacother. 2004;38:859–67.CrossRefPubMedGoogle Scholar
  9. 9.
    Kirchhof P, Sipido KR, Cowie MR, Eschenhagen T, Fox KAA, Katus H, et al. The continuum of personalized cardiovascular medicine: a position paper of the European Society of Cardiology. Eur Heart J. 2014. doi: 10.1093/eurheartj/ehu312.PubMedCentralGoogle Scholar
  10. 10.
    Rupp MT, DeYoung M, Schondelmeyer SW. Prescribing problems and pharmacist interventions in community practice. Med Care. 1992;30(10):926–40.CrossRefPubMedGoogle Scholar
  11. 11.
    Dean B, Schachter M, Vincent C, Barber N. Prescribing errors in hospital inpatients: their incidence and clinical significance. Qual Saf Health Care. 2002;11(4):340–4.CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Velo GP, Minuz P. Medication errors: prescribing faults and prescription errors. Br J Clin Pharmacol. 2009;67(6):624–8.CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Institute of Medicine. Preventing medication errors: quality chasm series. Washington, DC: National Academy Press; 2006.Google Scholar
  14. 14.
    European Medicines Agency. Medication errors. http://www.ema.europa.eu/ema/index.jsp?curl=pages/special_topics/general/general_content_000570.jsp. Last accessed 15-3-2015.
  15. 15.
    Hanlon JT, Schmader KE, Semla TP. Update of studies on drug-related problems in older adults. J Am Geriatr Soc. 2013;61(8):1365–8.CrossRefPubMedGoogle Scholar
  16. 16.
    van Doormaal JE, van den Bemt PM, Mol PG, Zaal RJ, Egberts AC, Kosterink JG, et al. Medication errors: the impact of prescribing and transcribing errors on preventable harm in hospitalised patients. Qual Saf Health Care. 2009;18(1):22–7.CrossRefPubMedGoogle Scholar
  17. 17.
    Basger BJ, Moles RJ, Chen TF. Application of drug-related problem (DRP) classification systems: a review of the literature. Eur J Clin Pharmacol. 2014;70:799–815.CrossRefPubMedGoogle Scholar
  18. 18.
    Kaufmann CP, Stämpfli D, Hersberger KE, et al. Determination of risk factors for drug-related problems: a multidisciplinary triangulation process. BMJ Open. 2015;5(3):e006376.CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Allemann SS, van Mil JW, Botermann L, Berger K, Griese N, Hersberger KE. Pharmaceutical care: the PCNE definition 2013. Int J Clin Pharm. 2014;36(3):544–55.CrossRefPubMedGoogle Scholar
  20. 20.
    Burke JM, Miller WA, Spencer AP, et al. Clinical pharmacist competencies. Pharmacotherapy. 2008;28:806–15.CrossRefPubMedGoogle Scholar
  21. 21.
    European Association of Faculties of Pharmacy. EAFP/EPSA joint statement. http://eafponline.eu/wp-content/uploads/2013/04/EAFP-EPSA-Joint-Symposium.pdf. Last accessed 15-3-2015.

Copyright information

© Springer International Publishing 2016

Authors and Affiliations

  • J. W. Foppe van Mil
    • 1
    Email author
  • Tommy Westerlund
    • 1
  • Lawrence Brown
    • 1
  • Timothy F. Chen
    • 1
  • Martin Henman
    • 1
  • Kurt Hersberger
    • 1
  • James McElnay
    • 1
  • Martin Schulz
    • 1
  1. 1.Van Mil ConsultancyZuidlarenThe Netherlands

Personalised recommendations